Ilya Goldshleger - 22 Jan 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol
RXST
Transactions as of
22 Jan 2024
Transactions value $
$-145,500
Form type
4
Filing time
22 Jan 2024, 19:48:55 UTC
Previous filing
10 Jan 2024
Next filing
02 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Options Exercise $94,500 +5,000 +18.9% $18.90 31,475 22 Jan 2024 Direct
transaction RXST Common Stock Sale $-240,000 -5,000 -15.9% $48.00 26,475 22 Jan 2024 Direct F1
holding RXST Common Stock 1,372 22 Jan 2024 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Stock Option (right to buy) Options Exercise $0 -5,000 -34.8% $0.000000 9,360 22 Jan 2024 Common Stock 5,000 $18.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2023 by the Reporting Person.